Primary signet ring cell carcinoma of the pancreatic head: A case report

Primary signet ring cell carcinoma of the pancreatic head: A case report

Abstract Pancreatic SRCC is a rare, aggressive tumor. Given limited evidence and the risk of side effects, physicians may elect to withhold chemotherapy in select patients, with the exception of neoadjuvant chemotherapy use to facilitate resectability.

Bibliographic Details
Main Authors: Dheeraj Alexander, Lewis Rashid, Michael Hollis, Srinivas Kavuturu
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Clinical Case Reports
Subjects:
chemotherapy
pancreatic cancer
pancreaticoduodenectomy
Signet ring cell carcinoma
Online Access:https://doi.org/10.1002/ccr3.2475
id doaj-5e185fbd335d463580a4223c00fa4f69
record_format Article
spelling doaj-5e185fbd335d463580a4223c00fa4f692020-11-25T01:35:07ZengWileyClinical Case Reports2050-09042019-11-017112235223810.1002/ccr3.2475Primary signet ring cell carcinoma of the pancreatic head: A case reportDheeraj Alexander0Lewis Rashid1Michael Hollis2Srinivas Kavuturu3Department of General Surgery Michigan State University Lansing MI USADepartment of General Surgery Michigan State University Lansing MI USADepartment of General Surgery Michigan State University Lansing MI USADepartment of General Surgery Michigan State University Lansing MI USAAbstract Pancreatic SRCC is a rare, aggressive tumor. Given limited evidence and the risk of side effects, physicians may elect to withhold chemotherapy in select patients, with the exception of neoadjuvant chemotherapy use to facilitate resectability.https://doi.org/10.1002/ccr3.2475chemotherapypancreatic cancerpancreaticoduodenectomySignet ring cell carcinoma
collection DOAJ
language English
format Article
sources DOAJ
author Dheeraj Alexander
Lewis Rashid
Michael Hollis
Srinivas Kavuturu
spellingShingle Dheeraj Alexander
Lewis Rashid
Michael Hollis
Srinivas Kavuturu
Primary signet ring cell carcinoma of the pancreatic head: A case report
Clinical Case Reports
chemotherapy
pancreatic cancer
pancreaticoduodenectomy
Signet ring cell carcinoma
author_facet Dheeraj Alexander
Lewis Rashid
Michael Hollis
Srinivas Kavuturu
author_sort Dheeraj Alexander
title Primary signet ring cell carcinoma of the pancreatic head: A case report
title_short Primary signet ring cell carcinoma of the pancreatic head: A case report
title_full Primary signet ring cell carcinoma of the pancreatic head: A case report
title_fullStr Primary signet ring cell carcinoma of the pancreatic head: A case report
title_full_unstemmed Primary signet ring cell carcinoma of the pancreatic head: A case report
title_sort primary signet ring cell carcinoma of the pancreatic head: a case report
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2019-11-01
description Abstract Pancreatic SRCC is a rare, aggressive tumor. Given limited evidence and the risk of side effects, physicians may elect to withhold chemotherapy in select patients, with the exception of neoadjuvant chemotherapy use to facilitate resectability.
topic chemotherapy
pancreatic cancer
pancreaticoduodenectomy
Signet ring cell carcinoma
url https://doi.org/10.1002/ccr3.2475
work_keys_str_mv AT dheerajalexander primarysignetringcellcarcinomaofthepancreaticheadacasereport
AT lewisrashid primarysignetringcellcarcinomaofthepancreaticheadacasereport
AT michaelhollis primarysignetringcellcarcinomaofthepancreaticheadacasereport
AT srinivaskavuturu primarysignetringcellcarcinomaofthepancreaticheadacasereport
_version_ 1725068456905146368

Similar Items